Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Mourez

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Ebiomedicine|December 5, 2018
HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendorsThomas Mourez, Véronique Lemée, Valérie Delbos, et al.
AIDS (London, England)|October 19, 2016
First report of transmission of a highly resistant strain of HIV-1 group OGuillemette Unal, Thomas Mourez, Marie Leoz, et al.
AIDS (London, England)|August 15, 2013
In-vitro phenotypic susceptibility of HIV-1 'non-B' integrase inhibitors naive clinical isolates to dolutegravir and raltegravirCharlotte Charpentier, Mélanie Bertine, Benoit Visseaux, et al.
Plos Pathogens|October 7, 2009
Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factorGrégory Caignard, Anastassia V Komarova, Mehdi Bouraï, et al.
AIDS (London, England)|January 6, 2016
First evidence of transmission of an HIV-1 M/O intergroup recombinant virusPaul Alain Ngoupo, Serge Alain Sadeuh-Mba, Fabienne De Oliveira, et al.
Journal of Clinical Microbiology|June 28, 2013
Algorithm-based prediction of HIV-1 subtype D coreceptor useJulia Dina, Stephanie Raymond, Anne Maillard, et al.
AIDS (London, England)|April 24, 2018
Detection of numerous HIV-1/MO recombinants in FranceFabienne De Oliveira, Pierre Cappy, Véronique Lemée, et al.
The Journal of Antimicrobial Chemotherapy|February 22, 2019
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patientsAnne-Genevieve Marcelin, Maxime Grude, Charlotte Charpentier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2017
Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line RegimenStéphanie Raymond, Florence Nicot, Coralie Pallier, et al.
Journal of Clinical Microbiology|May 1, 2015
Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-RibavirinSylvie Larrat, Sophie Vallet, Sandra David-Tchouda, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Ebiomedicine|December 5, 2018
HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendorsThomas Mourez, Véronique Lemée, Valérie Delbos, et al.
AIDS (London, England)|October 19, 2016
First report of transmission of a highly resistant strain of HIV-1 group OGuillemette Unal, Thomas Mourez, Marie Leoz, et al.
AIDS (London, England)|August 15, 2013
In-vitro phenotypic susceptibility of HIV-1 'non-B' integrase inhibitors naive clinical isolates to dolutegravir and raltegravirCharlotte Charpentier, Mélanie Bertine, Benoit Visseaux, et al.
Plos Pathogens|October 7, 2009
Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factorGrégory Caignard, Anastassia V Komarova, Mehdi Bouraï, et al.
AIDS (London, England)|January 6, 2016
First evidence of transmission of an HIV-1 M/O intergroup recombinant virusPaul Alain Ngoupo, Serge Alain Sadeuh-Mba, Fabienne De Oliveira, et al.
Journal of Clinical Microbiology|June 28, 2013
Algorithm-based prediction of HIV-1 subtype D coreceptor useJulia Dina, Stephanie Raymond, Anne Maillard, et al.
AIDS (London, England)|April 24, 2018
Detection of numerous HIV-1/MO recombinants in FranceFabienne De Oliveira, Pierre Cappy, Véronique Lemée, et al.
The Journal of Antimicrobial Chemotherapy|February 22, 2019
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patientsAnne-Genevieve Marcelin, Maxime Grude, Charlotte Charpentier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2017
Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line RegimenStéphanie Raymond, Florence Nicot, Coralie Pallier, et al.
Journal of Clinical Microbiology|May 1, 2015
Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-RibavirinSylvie Larrat, Sophie Vallet, Sandra David-Tchouda, et al.
Pageof 3